Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,231.8
-7.4 (-0.23%)

 

  • STI Straits Times Index
    3,231.8
    -7.4 (-0.23%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,593.5
    -3.7 (-0.23%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,323.7
    -247.8 (-0.93%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,909.9
    4.6 (0.16%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,141.5
    -178.3 (-0.76%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,098.9
    -43.6 (-0.71%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,139.2
    16.8 (0.79%)
    Index delayed 20 minutes
  • XAO XAO
    6,840.8
    35.2 (0.52%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,018.9M
  • Value: 1,045.8M
  • Rise: 152
  • Fall: 171
  • Unch: 506

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.198+0.005
Golden Agri-Res0.245-0.020
YZJ Shipbldg SGD0.970+0.015
Tritech0.029+0.005
Mapletree NAC Tr1.150-0.010
BreadTalk0.620+0.080
Yoma Strategic0.375+0.050
ComfortDelGro2.320-0.060
Ascendas Reit2.900-0.020
AusGroup^0.030-0.002

World Indices

World Indices
Name Last Change
Nasdaq 8,482.1 -4.0
HSI 26,323.7 -247.8
HSCEI 10,427.4 -91.7
Jakarta 6,098.9 -43.5
Nikkei 225 23,141.5 -178.3
SSE Comp 2,909.9 +4.6
Shanghai A 3,048.6 +4.9
Shanghai B 258.2 -0.4
PSE Comp 0.0
KOSPI 2,139.2 +16.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

APREA THERAPEUTICS INC APREA THERAPEUTICS
Updated on 13 Nov 2019 (End of trading day)
Last (USD): 24.500 Change: +0.490 High: 24.750 Remarks: -
Change (%): +2.04 Low: 23.700
Open 23.910 Yesterday's Close 24.01
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 45,861 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.74918 Trailing EPS (USD) e -0.74918 NAV (USD) b 2.9505
PE a - Trailing PE f - Price / NAV b 8.3037
Dividend (USD) d - Cash In Hand (USD) g 3.1686 Issued & Paid-up Shares c 20,727,000
Dividend Yield (%) d - Price / Cash In Hand g 7.732 Treasury Shares h -
Beta - 75 Daysi 2.197 R-Squared - 75 Days(%)i 8.16 Market Cap (M) 507.812
Beta - 500 Daysi 2.004 R-Squared - 500 Days (%)i 8.72 Enterprise Value (M) 442.135
Piotroski F Score 2 Exchange Code APRE Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 47.9
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 18 Oct 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 25 Sep 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference APREA THERAPEUTICS INC NASDAQ 507.812 - - 8.3037 -
Industry Pharmaceuticals: Major NASDAQ 1,448.675 312.385 33.672 2.1749 0.011
Local Peer SANOFI SPON ADR ECH REP 1/2 ORD EUR2 LEVEL II NASDAQ 114,324.176 22.437 27.795 1.7814 2.518
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 5,699.065 8.097 8.852 1.1390 3.570
Local Peer REATA PHARMACEUTICALS INC NASDAQ 5,692.592 - - -170.0653 -
Local Peer ALLAKOS INC NASDAQ 3,654.330 - - 24.0180 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 3,059.210 - - 8.7933 -
Local Peer RA PHARMACEUTICALS INC NASDAQ 2,201.578 - - 7.4945 -
Local Peer TRICIDA INC NASDAQ 1,813.601 - - 5.2288 -
Local Peer AKCEA THERAPEUTICS INC NASDAQ 1,808.533 - - 5.5564 -
Local Peer APELLIS PHARMACEUTICALS INC NASDAQ 1,806.753 - - 12.9458 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 1,745.536 - - 4.1509 -
Local Peer GOSSAMER BIO INC NASDAQ 1,441.610 - - 3.2657 -
Local Peer CONSTELLATION PHARMACEUTICALS INC NASDAQ 1,141.230 - - 23.7011 -
Other Local Peers Y-MABS THERAPEUTICS INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), PRINCIPIA BIOPHARMA INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), ATHENEX INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), DOVA PHARMACEUTICALS INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), PETIQ INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), AKORN INC (NASDAQ), EVOLUS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), AC IMMUNE SA (NASDAQ), FORTY SEVEN INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), BEYONDSPRING INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), 89BIO INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), GAMIDA CELL LTD (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), VERU INC (NASDAQ), OBSEVA SA (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), IMMUNIC INC (NASDAQ), ESSA PHARMA INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), THE FS ALSEC ALPHASECTOR (NASDAQ), NOVAN INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), EYENOVIA INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), EDESA BIOTECH INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), ENTERA BIO LTD (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), GEMPHIRE THERAPEUTICS INC (NASDAQ), SIENNA BIOPHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 345,485.575 22.585 24.414 5.9351 2.728
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 227,110.367 17.968 19.225 4.3239 1.875
Global Peer MERCK & CO INC NYSE 215,950.024 34.719 23.188 8.0464 2.389
Global Peer PFIZER INC NYSE 202,548.792 18.163 12.491 3.1121 3.895
Global Peer ABBVIE INC NYSE 128,154.541 22.654 39.566 -15.5793 4.558
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 125,470.594 58.321 61.169 10.3149 2.767
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 111,402.584 23.060 19.221 7.6795 4.556
Global Peer ELI LILLY AND COMPANY NYSE 108,293.175 33.507 25.377 32.0153 2.196
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 107,357.958 17.559 18.696 13.2545 1.973
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 95,785.959 19.469 16.843 5.4276 2.730
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), CHINARES PHARMA (HKEx), INNOVENT BIO-B (HKEx), CMS (HKEx), HENLIUS-B (HKEx), JUNSHI BIO-B (HKEx), SSY GROUP (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CHINAGRANDPHARM (HKEx), ZYMEWORKS INC (NYSE), CSTONE PHARMA-B (HKEx), CANSINOBIO-B (HKEx), UNITED LAB (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), FUSEN PHARM (HKEx), HUA MEDICINE-B (HKEx), IGBB (Bursa), TOT BIOPHARM-B (HKEx), LANNETT CO INC (NYSE), DAWNRAYS PHARMA (HKEx), AFT PHARMACEUTICALS LTD (ASX), NC HEALTHCARE (HKEx), BIOMX INC (NYSE American), CHARMACY PHAR (HKEx), Merck Tbk. (IDX), KOTRA (Bursa), Phapros Tbk. (IDX), PALLA PHARMA LTD (ASX), NEP INTERLONG (HKEx), IP (SET), MEDLAB CLINICAL LIMITED (ASX), AGEX THERAPEUTICS INC (NYSE American), NOVA (Bursa), Hyphens Pharma (SGX), BIOHLDG (Bursa), ZOMEDICA PHARMACEUTICALS CORP (NYSE American), NOXOPHARM LTD (ASX), MMJ GROUP HOLDINGS LTD (ASX), SINOLIFE UTD (HKEx), EXOPHARM LTD (ASX), RECCE PHARMACEUTICALS LTD (ASX), CRESO PHARMA LTD (ASX), Star Pharm^ (SGX), RACE ONCOLOGY LTD (ASX), FARMAFORCE LTD (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), SUDA PHARMACEUTICALS LTD (ASX), FIJI KAVA LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.320
+1.32 %
10 Days -+0.350
+1.45 %
20 Days -+4.020
+19.63 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 15.100 - 27.870 Change From 1 Year Low +9.400 % Change From 1 Year Low (%) +62.25
Change From 1 Year High -3.370 % Change From 1 Year High (%) -12.09
2 Years Range 15.100 - 27.870 Change From 2 Years Low +9.400 % Change From 2 Years Low (%) +62.25
Change From 2 Years High -3.370 % Change From 2 Years High (%) -12.09
5 Years Range 15.100 - 27.870 Change From 5 Years Low +9.400 % Change From 5 Years Low (%) +62.25
Change From 5 Years High -3.370 % Change From 5 Years High (%) -12.09
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded in 2002 and is headquartered in Boston, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
13 Nov 2019 23.910 24.750 23.700 24.500 45,861 -
12 Nov 2019 24.570 24.970 23.850 24.010 109,415 -
11 Nov 2019 24.470 25.255 23.790 24.990 52,922 -
08 Nov 2019 24.120 25.130 23.359 24.875 40,820 -
07 Nov 2019 25.210 25.240 23.725 24.180 100,864 -
06 Nov 2019 25.550 25.550 23.855 25.000 40,729 -
05 Nov 2019 24.900 25.600 24.220 24.800 17,842 -
04 Nov 2019 25.000 25.720 24.390 24.980 32,495 -
01 Nov 2019 24.220 25.773 24.220 24.970 70,957 -
31 Oct 2019 24.120 24.735 23.120 24.150 39,239 -
30 Oct 2019 24.970 24.980 22.710 23.680 51,383 -
29 Oct 2019 24.620 25.500 23.785 24.970 76,113 -
28 Oct 2019 24.500 25.499 22.690 24.840 88,133 -
25 Oct 2019 25.910 26.790 23.140 25.590 168,700 -
24 Oct 2019 24.890 26.660 24.400 25.700 121,328 -
23 Oct 2019 25.000 25.500 23.560 24.800 171,965 -
22 Oct 2019 26.000 26.770 24.540 24.700 148,519 -
21 Oct 2019 21.800 27.870 21.747 26.000 245,241 -
18 Oct 2019 19.940 21.920 19.940 21.400 35,741 -
17 Oct 2019 19.180 21.000 19.018 20.480 48,073 -
16 Oct 2019 19.120 19.680 19.110 19.500 14,564 -
15 Oct 2019 19.330 19.692 19.046 19.330 9,281 -
Summary
Current 2 Weeks
(31 Oct 2019 to 13 Nov 2019)
24.120 25.773 23.120 24.500 551,144 -
Previous 2 Weeks
(17 Oct 2019 to 30 Oct 2019)
19.180 25.773 19.018 23.680 1,155,196 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.